| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Revenue | $9.9M | +53.9% |
| Cost of Revenue | $4.9M | +26.1% |
| Gross Profit | $5.0M | +96.2% |
| R&D Expense | $2.4M | -58.1% |
| SG&A Expense | $39.6M | -5.4% |
| Operating Income | -$37.7M | +18.8% |
| Pre-tax Income | -$46.1M | -105.3% |
| Income Tax | $7K | +100.3% |
| Net Income | -$46.1M |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Accounts Receivable | $1.4M | -49.7% |
| Inventory | $1.4M | -16.8% |
| Current Assets | $6.7M | +27.4% |
| Total Assets | $37.1M | -5.1% |
| Current Liabilities | $27.8M | +6.4% |
| Long-term Debt | $6.2M | +80.7% |
| Total Liabilities | $37.4M | +11.6% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.1M | +45.0% |
| Capital Expenditures | $26K | -40.9% |
| Investing Cash Flow | $1K | +100.1% |
| Financing Cash Flow | $13.1M | -33.3% |
| Free Cash Flow | -$10.1M | +45.0% |
| -130.3% |
| EPS (Basic) | -$1.01 | -38.4% |
| EPS (Diluted) | -$1.01 | -34.7% |
| Stockholders' Equity |
| -$336K |
| -106.1% |